title: Role of Ca(2+)-calmodulin dependent phospholamban phosphorylation on the relaxant effect of beta-adrenergic agonists.
abstract: The role of the Ca(2+)-calmodulin dependent pathway of phospholamban phosphorylation on the relaxant effect of beta-adrenergic agonists was studied in isolated perfused rat heart. Administration of the calmodulin antagonist W7 or lowering [Ca]o from 1.35 mM (control) to 0.25 mM, were used as experimental tools to inhibit the Ca(2+)-calmodulin dependent protein kinase activity. 3 x 10(-8) M isoproterenol increased cAMP levels from 0.613 +/- 0.109 pmol/mg wet weight to 1.581 +/- 0.123, phospholamban phosphorylation from 36 +/- 6 pmol 32P/mg protein to 277 +/- 26 and decreased time to half relaxation (t1/2) from 61 +/- 2 msec to 39 +/- 2. Simultaneous perfusion of isoproterenol with 10(-6) M W7, decreased phospholamban phosphorylation to 170 +/- 23 and prolongated t1/2 to 47 +/- 3 but did not affect the increase either in cAMP levels or myocardial contractility produced by isoproterenol. Similar effects on phospholamban phosphorylation and myocardial relaxation were obtained when isoproterenol was perfused in low [Ca]o. Low [Ca]o did not affect the increase in cAMP elicited by isoproterenol but offset the positive inotropic effect of the beta-agonist. The results suggest a physiological role of the Ca(2+)-calmodulin dependent phospholamban phosphorylation pathway as a mechanism that supports, in part, the beta-adrenergic cardiac relaxant effect.
authors.affiliation: Centro de Investigaciones Cardiovasculares, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, Argentina.
authors.forename: L
authors.initials: L
authors.lastname: Vittone
authors.forename: C
authors.initials: C
authors.lastname: Mundiña
authors.forename: G
authors.initials: G
authors.lastname: Chiappe de Cingolani
authors.forename: A
authors.initials: A
authors.lastname: Mattiazzi
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D002118:Calcium / Q000378:metabolism*; D002135:Calcium-Binding Proteins / Q000378:metabolism*; D002147:Calmodulin / Q000037:antagonists & inhibitors / Q000378:metabolism*; D000242:Cyclic AMP / Q000378:metabolism; D003720:Densitometry; D006321:Heart / Q000187:drug effects / Q000502:physiology*; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology*; D009126:Muscle Relaxation / Q000187:drug effects; D010477:Perfusion; D010766:Phosphorylation; D051381:Rats; D017208:Rats, Wistar; D011943:Receptors, Adrenergic, beta / Q000378:metabolism; D013449:Sulfonamides / Q000494:pharmacology; D000099211:Phospholamban
chemical_list: D002118:Calcium; D002135:Calcium-Binding Proteins; D002147:Calmodulin; D000242:Cyclic AMP; D007545:Isoproterenol; D011943:Receptors, Adrenergic, beta; D013449:Sulfonamides; D000099211:Phospholamban; C017967:W 7